IJGC conversations

IJGC conversations 2025 June Editor's Choice

In this episode of the IJGC conversations 2025 June Editor's Choice, Editorial Fellow Louisa Proppe, Sofia Bigardi and Rosanu Nelia Marina discusses the contents of the 2025 June issue of IJGC. 

ctDNA in Endometrial Cancer with Ilaria Capasso, Camilla Nero, and Evelyn A. Reynolds.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Ilaria Capasso, Camilla Nero, and Evelyn A. Reynolds to discuss ctDNA in Endometrial Cancer .
Dr. Capasso completed her OBGYN residency at Fondazione Policlinico Agostino Gemelli (Rome, Italy), where she worked in the Gynecologic Oncology Unit with a focus on clinical and translational research in endometrial cancer. From May 2022 to May 2023, she was a Visiting Research Fellow at Mayo Clinic (Rochester, MN, USA), leading projects on AI, the microbiome, and ctDNA in endometrial cancer. She is currently a consultant in the Gynecologic Oncology Unit at Gemelli and continues to collaborate with Mayo Clinic as a research collaborator.
Camilla Nero, MD, PhD, is a clinician-scientist in the Division of Gynecologic Oncology at Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Rome, where her translational work focuses on gynecological cancers. She has authored key studies on dual CDK12/13 inhibition in patient-derived ovarian cancer organoids and numerous reviews on treatment resistance and novel therapeutic strategies. In 2024, she was awarded the AIRC Next Gen Clinician Scientist Grant to support her independent research in gynecological cancers at Gemelli.
Evelyn A. Reynolds, M.D., is a board-certified Gynecologic Oncologist specializing in surgical care for women with gynecologic cancers. She has hed faculty positions at the University of Kansas and Morehouse School of Medicine. Since returning to Mayo Clinic in 2023, she has also expanded her academic role, focusing her research on the early detection of endometrial cancer, optimizing surgical outcomes and reducing healthcare disparities.

IDEAL Framework: Robotics Innovation and Evaluation with Hani Marcus

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Hani Marcus to discuss the IDEAL Framework. Mr. Marcus is a Consultant Neurosurgeon at the National Hospital for Neurology and Neurosurgery and Honorary Associate Professor at the UCL Queen Square Institute of Neurology.

Modified Radical Hysterectomy for Stage IB1 Cervical Cancer with Koji Matsuo

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Koji Matsuo to discuss Modified Radical Hysterectomy for Stage IB1 Cervical Cancer.
Dr. Matsuo is a professor in the area of gynecologic oncology. Equally attentive to patient care, he devotes his work to scholarly activity related to patient outcomes, quality improvement, and healthcare service research in gynecologic malignancies.

Risk Factor for Unsuccessful SLN Mapping with Félix Boria

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Félix Boria to discuss the Risk Factor for Unsuccessful SLN Mapping.
Dr. Boria is an attending physician of the gynecologic oncology division at the Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain. He completed his PhD at the Universidad Autónoma de Madrid, where his research focused on PET/CT in advanced ovarian cancer.

IJGC conversations 2025 May Editor's Choice

In this episode of the IJGC conversations 2025 May Editor's Choice, Editorial Fellow Christian Braun, Julia Gelissen and Kyra Fischer discusses the contents of the 2025 May issue of IJGC. 

SUGAR Initiative: Glycemic control in the perioperative period with Jolyn Taylor

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Jolyn Taylor to discuss SUGAR Initiative: Glycemic control in the perioperative period. 
Dr. Taylor is an Associate Professor of Gynecologic Oncology at MD Anderson Cancer Center. She serves as the Associate Chief Quality and Value Officer and the Patient Safety Quality Officer for the Division of Surgery and focuses her research on ways to improve the quality of patient care.

HIPEC in Platinum-Sensitive Ovarian Cancer (HORSE Trial) with Anna Fagotti

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Anna Fagotti to discuss HIPEC in Platinum-Sensitive Ovarian Cancer (HORSE Trial).
Anna Fagotti is a Professor and Consultant of Gynecologic Oncology at A. Gemelli University Hospital Foundation IRCCS. She is the President of ESGO - European Society of Gynaecological Oncology. Her research interests are Obstetrics and Gynecology, Gynecologic Oncology, Advanced Ovarian Cancer, Gynecological Cancer, and Laparoscopic Surgery.

Molecular Targets in Endometrial Cancer: Real World Outcomes (ECMT2) with Angeles Alvarez Secord

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr Angeles Alvarez Secord to discuss Molecular Targets in Endometrial Cancer: Real World Outcomes (ECMT2).
Angeles Alvarez Secord, MD, MHSc, is a professor in the Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Duke University Heath System. She received her undergraduate degree with honors from Carroll College in Helena, Montana and graduated AOA with honors from the University of Washington School of Medicine in Seattle, Washington. Dr. Secord completed her residency in obstetrics and gynecology and her fellowship in gynecologic oncology at the Duke University Medical Center in Durham, North Carolina. Upon completing her fellowship in 2001, she joined the Division of Gynecologic Oncology at Duke. She is currently Director of Gynecologic Oncology Clinical Trials, Associate Director of Clinical Research, Gynecology Oncology, and one of the Principal Investigators for NRG Oncology at the Duke Cancer Institute. Dr. Secord serves on the GOG Foundation Board of Directors. She is passionate about mentoring the next generation of investigators and serves as the GOG Foundation Education and Mentoring Chair and the NRG Oncology Investigator and Career Development Committee Vice-Chair. Dr. Secord is a fellow of the American College of Obstetricians and Gynecologists and an active member of American Society of Clinical Oncology, American Gynecological & Obstetrical Society, Society of Gynecology & Oncology, and International Gynecologic Cancer Society as well as other professional organizations.

IJGC conversations 2025 April Editor's Choice

In this episode of the IJGC conversations 2025 April Editor's Choice, Editorial Fellow Stephanie Gill and Elise Mann Yates discusses the contents of the 2025 April issue of IJGC.